OTC ‘Bird Flu’-Killing Hand Sanitizer Has Favorable Risk/Benefit, Firm Says
This article was originally published in The Rose Sheet
Executive Summary
A new virucidal hand sanitizer capable of remaining on the skin for an extended period of time has a demonstrable benefit in the consumer environment, especially in the event of an avian flu pandemic, manufacturer Skinvisible Pharmaceuticals said
You may also be interested in...
Non-Alcohol Antiseptic Hand Products Should Prove Efficacy – NDAC
Marketers of non-alcohol-based consumer antiseptic products should be required to prove their products provide clinical benefit prior to sale, an FDA advisory panel unanimously agreed Oct. 20
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle